Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for MECP2
Z-value: 1.67
Motif logo
Transcription factors associated with MECP2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MECP2
|
ENSG00000169057.24 | MECP2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MECP2 | hg38_v1_chrX_-_154097731_154097746 | 0.27 | 1.6e-01 | Click! |
Activity profile of MECP2 motif
Sorted Z-values of MECP2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of MECP2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.7 | 10.2 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.6 | 4.7 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
| 1.4 | 4.3 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.4 | 4.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 1.2 | 3.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.1 | 8.0 | GO:0030421 | defecation(GO:0030421) |
| 1.1 | 3.3 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 1.1 | 3.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 1.1 | 5.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.0 | 7.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 1.0 | 19.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.9 | 6.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 | 2.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.9 | 1.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.8 | 1.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.8 | 2.3 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
| 0.8 | 4.5 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.7 | 4.4 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.7 | 2.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.7 | 2.8 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.7 | 4.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.7 | 2.0 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.7 | 3.9 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.7 | 4.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.6 | 1.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.6 | 0.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.6 | 2.6 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.6 | 2.5 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.6 | 1.9 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.6 | 0.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.6 | 1.8 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.6 | 3.6 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.6 | 0.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.6 | 6.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.6 | 2.9 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.6 | 0.6 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
| 0.6 | 1.7 | GO:2000412 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.6 | 1.7 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.6 | 6.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.6 | 3.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.6 | 2.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.5 | 5.5 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.5 | 0.5 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.5 | 2.7 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.5 | 2.2 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.5 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 | 1.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.5 | 2.7 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.5 | 3.7 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 0.5 | 3.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.5 | 0.5 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.5 | 0.5 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.5 | 0.5 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 0.5 | 3.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.5 | 3.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.5 | 2.9 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.5 | 1.5 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.5 | 1.5 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.5 | 1.9 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.5 | 8.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.5 | 1.0 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 0.5 | 2.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 | 7.5 | GO:0035878 | nail development(GO:0035878) |
| 0.5 | 1.9 | GO:1990834 | response to odorant(GO:1990834) |
| 0.5 | 1.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.5 | 2.3 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.5 | 1.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.5 | 1.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.5 | 2.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.5 | 1.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.5 | 1.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 | 0.4 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.4 | 1.7 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.4 | 1.7 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.4 | 0.8 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.4 | 1.7 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.4 | 1.2 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 0.4 | 1.2 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.4 | 2.5 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.4 | 2.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.4 | 0.8 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 0.4 | 0.8 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.4 | 3.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 | 3.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.4 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.4 | 3.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.4 | 2.4 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.4 | 1.6 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 1.9 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 | 2.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.4 | 1.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.4 | 1.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.4 | 1.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.4 | 0.4 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.4 | 1.1 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.4 | 1.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 | 1.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.4 | 1.5 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 1.1 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.4 | 1.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.4 | 1.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.4 | 1.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 | 1.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 | 1.4 | GO:0048627 | myoblast development(GO:0048627) |
| 0.4 | 1.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.4 | 2.1 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.4 | 1.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.4 | 0.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.4 | 1.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.3 | 1.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.3 | 1.7 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.3 | 1.7 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.3 | 1.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.3 | 2.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.3 | 1.0 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 0.3 | 1.0 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 0.3 | 2.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 1.0 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 0.3 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 | 1.0 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.3 | 3.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 | 3.6 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.3 | 1.6 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.3 | 1.0 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.3 | 1.0 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 | 1.9 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.3 | 2.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.3 | 1.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.3 | 5.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.3 | 0.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.3 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.3 | 1.6 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.3 | 1.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 1.2 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.3 | 0.9 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 | 0.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.3 | 1.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.3 | 1.8 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.3 | 0.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.3 | 0.9 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 0.3 | 1.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.3 | 2.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 0.9 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.3 | 0.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.3 | 1.2 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.3 | 1.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.3 | 2.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 | 3.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.3 | 3.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 | 1.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 | 7.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 | 1.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.3 | 1.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.3 | 1.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.3 | 0.9 | GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 0.3 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.3 | 5.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.3 | 2.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.3 | 0.6 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.3 | 2.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 6.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.3 | 0.3 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.3 | 4.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.3 | 1.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 | 0.3 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.3 | 0.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 | 0.8 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.3 | 0.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 0.8 | GO:0019089 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 0.3 | 1.4 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.3 | 2.8 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.3 | 0.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.3 | 1.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.3 | 1.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.3 | 2.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.3 | 0.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 | 2.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 | 2.7 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
| 0.3 | 3.0 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.3 | 0.5 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.3 | 1.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.3 | 0.5 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.3 | 1.1 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.3 | 1.6 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.3 | 0.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.3 | 0.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 | 1.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 2.9 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.3 | 0.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 | 2.6 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.3 | 0.8 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.3 | 0.5 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.3 | 2.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.3 | 1.0 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.3 | 0.5 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 | 0.5 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.3 | 3.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 | 0.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 1.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
| 0.2 | 0.7 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.2 | 1.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 1.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.2 | 0.7 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 | 0.7 | GO:0010933 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 0.2 | 3.2 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.2 | 1.0 | GO:0052251 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 | 1.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.2 | 0.2 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
| 0.2 | 2.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.2 | 1.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.2 | 1.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.2 | 1.0 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.2 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.2 | 0.9 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 | 0.9 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 | 1.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 0.5 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.2 | 4.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.2 | 1.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 | 0.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.2 | 2.3 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 | 2.5 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 | 0.5 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.2 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.2 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 1.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 | 0.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 | 5.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.2 | 0.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.2 | 0.7 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 | 0.2 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
| 0.2 | 7.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.2 | 1.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 2.9 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.2 | 0.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.2 | 5.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.2 | 0.4 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.2 | 1.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 1.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 | 0.2 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.2 | 2.4 | GO:0006771 | riboflavin metabolic process(GO:0006771) |
| 0.2 | 1.1 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.2 | 1.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 0.7 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.2 | 4.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.2 | 0.4 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.2 | 1.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 | 0.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 0.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 2.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 1.5 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.2 | 0.6 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.2 | 0.6 | GO:0009197 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 0.2 | 1.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 | 0.8 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.2 | 1.0 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.2 | 2.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 | 1.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.2 | 3.9 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 0.2 | 2.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 0.2 | GO:1990169 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) stress response to copper ion(GO:1990169) |
| 0.2 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 | 0.2 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.2 | 1.0 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.2 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 | 2.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.2 | 0.8 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.2 | 0.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 | 1.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 | 0.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 | 0.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.2 | 2.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 2.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.2 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.2 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 | 3.2 | GO:0051608 | histamine transport(GO:0051608) |
| 0.2 | 0.2 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
| 0.2 | 0.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.2 | 0.6 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 1.2 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.2 | 0.4 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.2 | 0.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 1.0 | GO:0060717 | chorion development(GO:0060717) |
| 0.2 | 0.2 | GO:1902724 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.2 | 0.6 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 | 1.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 0.8 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.2 | 0.8 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.2 | 0.6 | GO:2000832 | negative regulation of cortisol secretion(GO:0051463) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.2 | 1.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 2.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 | 0.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.2 | 0.6 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.2 | 1.0 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.2 | 2.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.2 | 0.2 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
| 0.2 | 1.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 | 4.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.2 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 | 0.6 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.2 | 0.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.2 | 0.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 | 1.5 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.2 | 0.9 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.2 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.2 | 1.7 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.2 | 1.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.2 | 4.0 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 | 0.9 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 | 2.6 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.2 | 0.5 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 | 1.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.2 | 2.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 0.4 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.2 | 0.4 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.2 | 2.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 | 2.7 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.2 | 0.5 | GO:0018011 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 1.1 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.2 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 | 0.5 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 3.0 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.2 | 4.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 0.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.2 | 1.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.2 | 0.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.2 | 4.6 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 1.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 0.7 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 | 1.2 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 | 1.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 0.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 0.7 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.2 | 0.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.2 | 0.7 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.2 | 1.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 1.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.2 | 4.3 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 | 0.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 | 0.5 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 | 5.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 1.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 0.5 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 0.2 | 2.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.2 | 3.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.2 | 0.8 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 0.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.2 | 2.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 | 1.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 3.0 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 | 0.7 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 | 0.7 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.2 | 1.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 2.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.2 | 0.5 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.2 | 1.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 | 0.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 | 0.5 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.2 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 2.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 | 1.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 0.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.2 | 0.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.2 | 0.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.2 | 0.6 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.2 | 0.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 | 0.6 | GO:1900450 | negative regulation of glutamate receptor signaling pathway(GO:1900450) negative regulation of NMDA glutamate receptor activity(GO:1904782) |
| 0.2 | 2.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 1.1 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.2 | 0.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 0.2 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 1.9 | GO:0021603 | cranial nerve formation(GO:0021603) |
| 0.2 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 0.2 | 0.3 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 | 4.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 | 0.2 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
| 0.2 | 0.2 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.2 | 0.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.2 | 0.8 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 | 0.6 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.2 | 2.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.2 | 1.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.2 | 1.7 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.2 | 1.7 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 3.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.2 | 2.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 | 1.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 | 0.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 | 0.5 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.2 | 0.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 | 0.1 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 1.9 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.4 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.1 | 3.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 5.0 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 | 2.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.1 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 | 0.7 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) positive regulation of chronic inflammatory response(GO:0002678) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.1 | 0.7 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 1.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 1.7 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.1 | 0.4 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 0.7 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.1 | 2.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 3.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 | 2.4 | GO:0051645 | Golgi localization(GO:0051645) |
| 0.1 | 1.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 | 1.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 2.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.6 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 0.1 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 | 0.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 0.4 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.1 | 0.4 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 | 0.6 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.1 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 0.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 1.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.1 | 0.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.1 | 0.4 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 0.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.1 | 0.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.1 | 5.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 | 1.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 4.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 0.5 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 3.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 | 0.9 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.1 | 0.4 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.1 | 1.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 2.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 | 0.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.1 | 0.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.1 | 1.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 1.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.1 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.3 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 | 2.1 | GO:0060022 | hard palate development(GO:0060022) |
| 0.1 | 1.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 2.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 0.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.1 | 1.2 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.1 | 0.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 4.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 1.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 1.4 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 5.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.1 | 0.6 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 | 0.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.1 | 0.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 1.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.1 | 0.4 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 | 0.5 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.1 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.1 | 1.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 1.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.5 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.1 | 1.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 | 1.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.1 | 0.7 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.1 | 0.4 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.1 | 0.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 0.4 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.1 | 0.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 | 1.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.5 | GO:0003285 | septum secundum development(GO:0003285) atrial septum secundum morphogenesis(GO:0003290) |
| 0.1 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.8 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 | 0.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.1 | 1.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 | 1.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 | 0.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.1 | 0.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 1.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.1 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) |
| 0.1 | 1.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 | 1.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 1.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.1 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.1 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 | 0.5 | GO:0048749 | compound eye development(GO:0048749) |
| 0.1 | 0.2 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 1.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 | 1.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.1 | 0.2 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 1.0 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.1 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.9 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.1 | 3.3 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 0.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 | 1.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 1.4 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 | 0.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 | 0.3 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 | 1.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.1 | 0.2 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 1.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.1 | 1.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 1.7 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 | 0.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 0.3 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 | 4.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.1 | 1.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.1 | 0.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 | 0.5 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 | 0.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 0.4 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.1 | 0.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.1 | 5.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 1.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 0.3 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) positive regulation of fibril organization(GO:1902905) |
| 0.1 | 0.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.1 | 0.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 0.2 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 | 0.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 0.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 | 1.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 | 1.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 | 1.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 1.6 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 2.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 1.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.1 | 0.3 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.1 | 0.4 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 | 1.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.1 | 0.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.2 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 0.1 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 | 1.0 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 1.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 | 1.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 0.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.1 | 1.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 0.3 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.1 | 0.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 0.3 | GO:0042946 | glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
| 0.1 | 0.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
| 0.1 | 0.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.1 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 9.1 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.1 | 0.7 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.1 | 0.4 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.1 | 0.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.1 | 0.4 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.5 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 | 1.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 | 0.6 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
| 0.1 | 0.6 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.1 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 0.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.1 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.1 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.2 | GO:0060932 | His-Purkinje system cell differentiation(GO:0060932) |
| 0.1 | 0.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.1 | 0.3 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.1 | 0.5 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.1 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 0.7 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.1 | 0.6 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.1 | 0.3 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.1 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.1 | 0.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 2.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.1 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.1 | 6.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.3 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 | 0.6 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 | 0.1 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.8 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.1 | 0.5 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 1.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.1 | 0.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.1 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.1 | 4.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
| 0.1 | 0.5 | GO:0048570 | notochord morphogenesis(GO:0048570) |
| 0.1 | 0.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 1.9 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.1 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.3 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 | 0.9 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 3.3 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.1 | 0.5 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.8 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 1.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.1 | 0.3 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 2.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.3 | GO:0071362 | cellular response to ether(GO:0071362) |
| 0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 | 0.3 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.1 | 5.4 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.3 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.1 | 0.3 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 | 2.8 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 | 0.9 | GO:2000347 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 0.7 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.2 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
| 0.1 | 0.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 1.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.1 | 0.1 | GO:0015827 | tryptophan transport(GO:0015827) |
| 0.1 | 0.2 | GO:0003273 | chronological cell aging(GO:0001300) cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.1 | 1.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.1 | 0.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.3 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
| 0.1 | 0.6 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
| 0.1 | 0.1 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.3 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 | 0.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 0.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 0.6 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 | 1.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.1 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.1 | 0.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 | 1.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 1.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.1 | 1.3 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.7 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.1 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.2 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 0.8 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 0.3 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.1 | 0.3 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.1 | 0.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 2.7 | GO:0019915 | lipid storage(GO:0019915) |
| 0.1 | 0.4 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 1.4 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.1 | 0.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.1 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 1.5 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 2.9 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.1 | 1.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 | 0.1 | GO:1903912 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.1 | 1.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.8 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 | 8.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.1 | 0.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.6 | GO:0007512 | adult heart development(GO:0007512) |
| 0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 1.7 | GO:0048799 | organ maturation(GO:0048799) |
| 0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.1 | 0.4 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 0.2 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.1 | 0.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 0.4 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.1 | 1.7 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.7 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.1 | 0.4 | GO:1902074 | response to salt(GO:1902074) |
| 0.1 | 0.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 0.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 | 2.0 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 0.3 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.1 | 0.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.1 | 0.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.1 | 0.6 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 0.3 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.1 | 0.8 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.1 | 2.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 0.6 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.3 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 0.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.8 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.1 | 1.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 | 1.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 1.8 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 3.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.1 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.1 | 0.4 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 0.1 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.1 | 0.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.1 | 0.3 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.1 | 0.3 | GO:0034164 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 0.4 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
| 0.1 | 0.4 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 0.3 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.1 | 0.1 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.1 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.3 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.1 | 0.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 | 1.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.1 | 1.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 | 0.4 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.1 | 0.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 | 0.3 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 | 0.3 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
| 0.1 | 0.2 | GO:0045556 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.1 | 1.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.2 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.1 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 0.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 0.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.1 | 0.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 0.2 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 0.1 | 0.1 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 0.1 | 0.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.1 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 3.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 0.1 | 0.1 | GO:0000966 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) RNA 5'-end processing(GO:0000966) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 | 1.0 | GO:0046051 | UTP metabolic process(GO:0046051) |
| 0.1 | 0.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 | 1.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 0.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.1 | 1.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.3 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
| 0.1 | 0.2 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 | 0.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.1 | 2.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 0.1 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.1 | 0.5 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.1 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 2.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 1.7 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.1 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 0.2 | GO:0052330 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.1 | 0.4 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) |
| 0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 | 1.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.3 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 | 4.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.6 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 0.2 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 | 0.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 | 1.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.1 | 1.6 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.1 | 0.5 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.1 | 0.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 0.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.1 | 2.0 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 | 0.2 | GO:0032907 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 0.1 | 1.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.1 | 0.1 | GO:0032214 | regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) |
| 0.1 | 0.3 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 | 0.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 0.2 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.1 | 0.5 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 1.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.1 | 0.3 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
| 0.1 | 0.7 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 1.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.1 | 0.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.1 | 0.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 | 0.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 0.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.1 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 | 0.7 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 | 0.5 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 0.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.0 | 0.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
| 0.0 | 0.3 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.0 | 0.2 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.0 | 0.0 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.0 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 | 0.1 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.0 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.0 | 3.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.1 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.0 | 1.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.0 | 0.1 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.0 | 0.1 | GO:0060026 | convergent extension(GO:0060026) |
| 0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.0 | 1.2 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.0 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.0 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 | 2.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.1 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.0 | 1.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
| 0.0 | 0.6 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.0 | 0.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 | 0.2 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.0 | 2.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.0 | 0.1 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 | 0.1 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 | 0.6 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.0 | 2.2 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.0 | 1.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.0 | 0.2 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
| 0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.0 | 0.9 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.1 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.0 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 | 0.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.0 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.0 | 0.1 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.0 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.0 | 0.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 | 0.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 | 0.0 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.0 | 1.3 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.0 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 2.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.0 | 0.6 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.0 | 0.3 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.0 | 0.0 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.0 | 3.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 | 0.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.0 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
| 0.0 | 0.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 | 0.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.0 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.0 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.0 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of corticosteroid hormone secretion(GO:2000848) regulation of glucocorticoid secretion(GO:2000849) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.0 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.0 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.0 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.0 | 0.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.0 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.0 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.0 | 0.1 | GO:0060327 | cytoplasmic actin-based contraction involved in cell motility(GO:0060327) endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.0 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.0 | 0.3 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
| 0.0 | 0.2 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 0.0 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 1.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.0 | 0.2 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 0.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.0 | 0.2 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.0 | 0.0 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.0 | 0.1 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.0 | 0.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.0 | 0.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
| 0.0 | 0.3 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
| 0.0 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.1 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 | 0.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.0 | 0.6 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.0 | 0.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 | 0.2 | GO:0071492 | response to UV-A(GO:0070141) cellular response to UV-A(GO:0071492) |
| 0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 0.1 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.0 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 | 0.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.1 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 0.0 | 0.1 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
| 0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.0 | 0.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.0 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.3 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
| 0.0 | 0.2 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.0 | 1.3 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.0 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.0 | 0.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 1.2 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.0 | 1.4 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 | 0.1 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.0 | 0.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.0 | 0.9 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.0 | 0.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.0 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.0 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.0 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.0 | 0.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.0 | 1.0 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.0 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.0 | 0.4 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.0 | 2.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.0 | 0.1 | GO:2000846 | regulation of corticosteroid hormone secretion(GO:2000846) |
| 0.0 | 0.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.0 | 0.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 | 0.9 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
| 0.0 | 0.1 | GO:2000330 | interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of T-helper 17 cell differentiation(GO:2000321) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
| 0.0 | 0.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 | 0.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.0 | 0.0 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
| 0.0 | 1.1 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.5 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
| 0.0 | 0.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.0 | 0.1 | GO:0000423 | macromitophagy(GO:0000423) |
| 0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.0 | 1.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.0 | 0.1 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.0 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 | 0.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.0 | 0.1 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.0 | 0.1 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 | 0.3 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.0 | 0.7 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.0 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 | 0.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.0 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.0 | 0.7 | GO:0072337 | modified amino acid transport(GO:0072337) |
| 0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.0 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.1 | GO:1903974 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of glial cell migration(GO:1903977) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.0 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.0 | 0.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.0 | 0.1 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.0 | 0.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
| 0.0 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
| 0.0 | 1.5 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.0 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 | 1.2 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.0 | 0.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.0 | 1.1 | GO:0008344 | adult locomotory behavior(GO:0008344) |
| 0.0 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 | 0.0 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.0 | 0.3 | GO:0032196 | transposition(GO:0032196) |
| 0.0 | 0.2 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
| 0.0 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 | 0.4 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.0 | 0.4 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
| 0.0 | 0.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 | 0.2 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.0 | 0.4 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 0.1 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
| 0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 | 0.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
| 0.0 | 0.8 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 | 0.0 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
| 0.0 | 0.4 | GO:0051261 | protein depolymerization(GO:0051261) |
| 0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 1.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 1.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 | 0.1 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.0 | 1.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 | 0.5 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
| 0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.0 | 0.6 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.0 | 0.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.0 | 0.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.0 | 1.8 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.0 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 | 1.7 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 | 0.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.0 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.0 | 0.0 | GO:0060448 | neuropeptide catabolic process(GO:0010813) dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.0 | 0.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 | 0.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 0.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.0 | 0.1 | GO:1990564 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.1 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.0 | 0.1 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 0.0 | 0.0 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 0.0 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.0 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.0 | 0.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.0 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.2 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 | 0.0 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 | 0.0 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.0 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.0 | 0.0 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 4.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.9 | 4.7 | GO:0032449 | CBM complex(GO:0032449) |
| 0.9 | 6.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.9 | 3.5 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.8 | 4.1 | GO:0031523 | Myb complex(GO:0031523) |
| 0.7 | 1.4 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.7 | 2.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.7 | 2.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.7 | 2.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.6 | 1.9 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.6 | 9.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.6 | 4.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.6 | 1.9 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.6 | 3.0 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.6 | 1.7 | GO:0071065 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.5 | 3.8 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.5 | 3.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.5 | 3.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.4 | 1.7 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.4 | 1.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.4 | 5.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.4 | 9.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.4 | 4.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.4 | 2.8 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.4 | 1.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.4 | 1.9 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.4 | 1.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.4 | 9.6 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 3.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.4 | 1.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.3 | 1.0 | GO:0030689 | Noc complex(GO:0030689) |
| 0.3 | 1.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.3 | 2.6 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 3.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 1.6 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 3.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.3 | 1.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.3 | 1.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.3 | 1.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.3 | 1.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 1.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.3 | 1.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.3 | 0.9 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.3 | 7.0 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 9.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 1.7 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.3 | 1.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.3 | 0.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 2.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 0.3 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.3 | 1.8 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.3 | 1.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.3 | 3.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.2 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 0.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.2 | 0.7 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.2 | 2.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 2.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.2 | 6.8 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 2.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.2 | 0.7 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.2 | 0.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.2 | 3.5 | GO:0005921 | gap junction(GO:0005921) |
| 0.2 | 1.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 1.6 | GO:0042825 | TAP complex(GO:0042825) |
| 0.2 | 0.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.2 | 2.8 | GO:0008091 | spectrin(GO:0008091) |
| 0.2 | 2.5 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 2.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.2 | 1.1 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.2 | 0.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.2 | 3.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 0.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.2 | 1.7 | GO:0000796 | condensin complex(GO:0000796) |
| 0.2 | 0.6 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.2 | 0.6 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.2 | 1.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.2 | 0.8 | GO:0044393 | microspike(GO:0044393) |
| 0.2 | 0.6 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.2 | 0.4 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.2 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 0.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 0.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.2 | 0.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.2 | 6.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.2 | 0.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 2.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 2.9 | GO:0042555 | MCM complex(GO:0042555) |
| 0.2 | 0.9 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.2 | 5.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.2 | 2.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.2 | 2.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.2 | 1.2 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 0.2 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.2 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 0.5 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.2 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 0.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.2 | 0.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.2 | 2.7 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 0.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.2 | 0.9 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.2 | 18.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.2 | 2.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.2 | 0.5 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.2 | 1.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 2.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.1 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 1.6 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 1.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 0.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 1.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.6 | GO:0031261 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
| 0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 0.6 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.1 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.1 | GO:0071920 | cleavage body(GO:0071920) |
| 0.1 | 1.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 1.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 1.2 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 0.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.1 | 0.4 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.1 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
| 0.1 | 0.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 1.0 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 1.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 0.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.1 | 2.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 1.4 | GO:0070449 | elongin complex(GO:0070449) |
| 0.1 | 1.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 1.1 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 0.4 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.1 | 0.4 | GO:0036029 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.1 | 1.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.1 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.1 | 2.6 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 0.3 | GO:0071754 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 0.1 | 0.6 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.1 | 1.1 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 0.9 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 0.1 | 1.6 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 1.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 0.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 0.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.1 | 0.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.1 | 0.4 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.1 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.9 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 1.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 1.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 1.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 1.3 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 0.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 3.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 0.3 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 9.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 8.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 2.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 0.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 0.5 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.1 | 1.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 1.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 0.9 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.1 | 1.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.1 | 1.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.1 | 6.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 0.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 9.8 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 1.0 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.3 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.1 | 2.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 1.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.1 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 1.0 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.1 | 6.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 4.1 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 4.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 2.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.2 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.1 | 5.1 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 1.4 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 0.3 | GO:0097229 | sperm end piece(GO:0097229) |
| 0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.1 | 1.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 2.2 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 19.8 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 38.3 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 2.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.2 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.1 | 4.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.4 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.1 | 2.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 1.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 2.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 0.4 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.1 | 0.2 | GO:0097462 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
| 0.1 | 1.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
| 0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.1 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 4.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 0.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.1 | 1.6 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.1 | 5.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 1.1 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.1 | 0.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 2.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 0.2 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 2.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 1.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.3 | GO:0005712 | chiasma(GO:0005712) |
| 0.1 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.7 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 1.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 6.5 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 6.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.1 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.1 | 2.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 3.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 4.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.5 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.1 | 0.2 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 0.8 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 4.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.1 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.0 | 0.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 1.0 | GO:1990752 | microtubule end(GO:1990752) |
| 0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.0 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 1.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.0 | 2.0 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.0 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.0 | 2.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.0 | 1.2 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.6 | GO:0000800 | lateral element(GO:0000800) |
| 0.0 | 0.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 3.1 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.0 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.0 | 0.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.0 | 0.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.0 | 0.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.0 | 42.7 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 0.1 | GO:1990879 | CST complex(GO:1990879) |
| 0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 3.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.0 | 5.9 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 9.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 2.7 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.0 | 0.1 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 2.1 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.4 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.0 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 5.9 | GO:0019867 | outer membrane(GO:0019867) |
| 0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 5.2 | GO:0031674 | I band(GO:0031674) |
| 0.0 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.0 | 1.2 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 2.2 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 1.6 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
| 0.0 | 3.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 0.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
| 0.0 | 0.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 0.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.0 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.0 | 1.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.5 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.0 | GO:1990745 | EARP complex(GO:1990745) |
| 0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 1.0 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.0 | 2.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.0 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.0 | 3.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.0 | 0.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.0 | 6.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.0 | 1.4 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 0.0 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 0.8 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 1.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 0.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.0 | GO:0034657 | GID complex(GO:0034657) |
| 0.0 | 0.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 1.5 | GO:0045121 | membrane raft(GO:0045121) |
| 0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 10.2 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 1.2 | 3.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 1.1 | 3.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.1 | 3.3 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.9 | 2.8 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.9 | 3.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.8 | 5.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.7 | 5.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.7 | 2.0 | GO:0070704 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.6 | 1.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.6 | 3.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.6 | 10.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.6 | 1.7 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.6 | 1.7 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.6 | 2.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.6 | 2.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.5 | 2.7 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.5 | 2.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.5 | 8.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.5 | 1.6 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.5 | 1.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.5 | 4.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.5 | 2.1 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.5 | 1.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.5 | 1.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.5 | 2.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.5 | 2.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.5 | 5.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.5 | 1.4 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.5 | 1.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.5 | 3.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.4 | 2.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.4 | 1.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.4 | 4.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 1.7 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 0.4 | 9.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.4 | 4.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.4 | 1.3 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 0.4 | 4.7 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.4 | 1.3 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.4 | 1.7 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.4 | 4.5 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.4 | 1.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.4 | 1.9 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.4 | 1.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.4 | 1.1 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.4 | 1.1 | GO:0032428 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.4 | 2.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.4 | 2.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.4 | 2.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.4 | 3.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.4 | 1.8 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.4 | 1.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.4 | 4.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.4 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.4 | 1.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.4 | 1.8 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.4 | 1.1 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.4 | 1.1 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.3 | 1.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.3 | 1.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
| 0.3 | 1.0 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 0.3 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.3 | 1.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 1.0 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.3 | 1.0 | GO:0047012 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 0.3 | 1.7 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.3 | 1.0 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.3 | 1.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.3 | 1.3 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.3 | 0.9 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.3 | 1.6 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.3 | 3.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.3 | 3.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.3 | 0.9 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.3 | 1.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.3 | 0.9 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.3 | 1.2 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.3 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.3 | 0.9 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.3 | 2.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.3 | 2.9 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
| 0.3 | 0.9 | GO:0070815 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.3 | 1.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.3 | 3.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 1.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.3 | 3.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 5.9 | GO:0019841 | retinol binding(GO:0019841) |
| 0.3 | 0.6 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.3 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.3 | 1.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.3 | 0.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.3 | 1.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.3 | 0.8 | GO:0004638 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 0.3 | 1.0 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.3 | 5.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 6.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.3 | 4.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.3 | 0.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.3 | 3.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.3 | 1.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.3 | 2.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.3 | 1.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.3 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 1.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.3 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.3 | 1.3 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 1.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.2 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 1.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.2 | 0.7 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.2 | 0.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.2 | 0.7 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.2 | 1.9 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 1.4 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.2 | 3.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 0.9 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.2 | 0.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.2 | 2.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.2 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.2 | 0.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.2 | 1.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.2 | 4.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 1.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.2 | 1.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 1.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.2 | 0.9 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 3.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.2 | 1.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 0.2 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.2 | 2.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.2 | 2.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 2.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 1.3 | GO:0042835 | BRE binding(GO:0042835) |
| 0.2 | 4.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 0.6 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 1.0 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 2.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 1.2 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.2 | 1.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.2 | 1.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.2 | 0.2 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.2 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 0.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.2 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.2 | 1.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.2 | 0.6 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.2 | 1.0 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 0.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 1.2 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.2 | 2.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 0.6 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.2 | 1.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.2 | 0.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.2 | 0.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.2 | 0.8 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.2 | 1.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.2 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.2 | 2.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.2 | 2.9 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 1.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.2 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.2 | 2.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.2 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.2 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.2 | 2.7 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.2 | 0.4 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.2 | 2.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 1.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.2 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.2 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 0.6 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.2 | 2.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.2 | 0.6 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.2 | 2.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 1.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 3.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.2 | 0.7 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.2 | 3.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 0.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.2 | 0.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 0.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.2 | 0.5 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 1.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 0.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.2 | 4.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.2 | 1.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.2 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.2 | 0.9 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 0.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.2 | 0.5 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.2 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 6.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 3.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 0.8 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 0.5 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.2 | 1.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 1.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.2 | 0.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.2 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 3.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.2 | 0.5 | GO:0044713 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 0.2 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.2 | 2.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.2 | 2.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.2 | 1.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.2 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.2 | 1.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.2 | 4.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 0.6 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 0.2 | 5.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 1.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.2 | 2.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 2.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.2 | 3.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.2 | 0.5 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 0.2 | 0.5 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.2 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 0.6 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 1.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.2 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 0.5 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.2 | 2.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.2 | 0.6 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.1 | 1.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.1 | 0.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.1 | 2.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.1 | 2.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.7 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 0.1 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 0.4 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 1.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 1.4 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.1 | 0.3 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.1 | 7.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 3.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 0.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 1.0 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.1 | 2.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 1.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.1 | 0.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.1 | 43.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 7.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 1.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 0.9 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.1 | 1.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 2.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 6.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.1 | 0.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.1 | 0.9 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 1.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.9 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.1 | 1.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 1.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.1 | 1.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 21.8 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 0.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.1 | 0.6 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.1 | 1.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 12.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.1 | 0.5 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.5 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.1 | 2.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 1.1 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.3 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 3.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.1 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 1.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.3 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.1 | 0.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.1 | 1.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 4.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 3.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 1.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 2.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 3.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.4 | GO:0016717 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.1 | 0.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 3.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 1.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 5.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 1.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.1 | 1.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.4 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.1 | 1.0 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.1 | 0.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 2.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 0.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 2.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 1.8 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.3 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 1.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.1 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.1 | 0.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 1.9 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.1 | 3.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 5.1 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 1.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.4 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 1.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 8.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 3.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.5 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 0.5 | GO:0050610 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 1.3 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.1 | 14.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 1.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.6 | GO:0016918 | retinal binding(GO:0016918) |
| 0.1 | 0.9 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 3.4 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 0.8 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 0.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.1 | 2.0 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 1.4 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 2.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.1 | 0.2 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 0.7 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 1.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 1.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.1 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
| 0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 1.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 1.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.1 | 1.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 5.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.2 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.1 | 1.2 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 0.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.1 | 0.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 0.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.1 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 0.5 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 1.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
| 0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 0.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 0.2 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 33.9 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.1 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 2.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 2.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 5.7 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 4.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 10.6 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 0.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 1.9 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 0.2 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.1 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.8 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.1 | 1.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.7 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.1 | 0.8 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
| 0.1 | 0.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 0.8 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.1 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 1.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 1.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.1 | 6.2 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.1 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.1 | 0.2 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.1 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
| 0.1 | 1.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.3 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 1.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 1.3 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 0.1 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.1 | 0.4 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 1.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.2 | GO:0061598 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.1 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 0.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.1 | 0.9 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.1 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.1 | 0.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cGMP-dependent protein kinase activity(GO:0004692) |
| 0.1 | 0.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.2 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.1 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 12.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 8.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 1.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 1.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
| 0.1 | 6.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 0.2 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 0.1 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
| 0.1 | 0.4 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 0.2 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.1 | 0.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 0.3 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.1 | 0.2 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.1 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 1.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 2.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.1 | 0.5 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.0 | 0.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.0 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.0 | 2.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.0 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 0.1 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.0 | 1.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.0 | 0.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.0 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.0 | 4.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.0 | 4.0 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 4.5 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.0 | 5.7 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
| 0.0 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.0 | 0.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 1.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 1.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.0 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 1.7 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.0 | 3.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.1 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 0.1 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.0 | 0.1 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.0 | 0.1 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
| 0.0 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.0 | 0.1 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.0 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.0 | 0.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.0 | 1.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.0 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.0 | 0.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.0 | 1.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.0 | 0.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.0 | 0.1 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.0 | 0.1 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.0 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.0 | 0.1 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.0 | 0.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.0 | 0.1 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.0 | 1.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.8 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.0 | 1.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.0 | 0.4 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 0.1 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 0.0 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.0 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.0 | 0.1 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.0 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.1 | GO:0047750 | cholestenol delta-isomerase activity(GO:0047750) |
| 0.0 | 0.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.0 | 0.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.0 | 1.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.9 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.0 | 8.6 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
| 0.0 | 1.7 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.0 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.0 | 0.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.1 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.0 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.0 | 0.1 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.0 | 0.1 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.0 | 0.1 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.0 | 5.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 0.0 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.0 | 1.9 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 0.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 0.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.0 | 0.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
| 0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.0 | 0.1 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
| 0.0 | 0.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.0 | 0.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 0.9 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 11.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 5.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.3 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.3 | 20.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.3 | 5.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.3 | 19.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.3 | 1.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 7.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 3.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.2 | 6.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 4.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 9.2 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.2 | 3.0 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 7.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.2 | 2.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 13.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 3.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 10.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 1.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 4.0 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 45.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 3.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 3.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 4.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 3.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 0.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 2.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 4.7 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 4.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 6.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 6.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 1.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 2.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 2.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 8.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 4.0 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 3.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 1.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 4.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 4.3 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 2.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 4.1 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 8.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 3.1 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 1.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 3.6 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 1.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 5.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 1.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 5.2 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 0.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 2.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 5.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 3.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 2.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 2.8 | PID P73PATHWAY | p73 transcription factor network |
| 0.1 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 1.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 0.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 3.5 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 1.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 2.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 1.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 2.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 2.7 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 0.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 1.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 1.0 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 1.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 1.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 2.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 6.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 1.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.0 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 4.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 1.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.5 | 0.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.5 | 8.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.4 | 6.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.4 | 9.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 0.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.4 | 9.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.3 | 5.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 1.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.3 | 1.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.3 | 4.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.3 | 3.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 6.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 7.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 2.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.2 | 12.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 6.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.2 | 3.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.2 | 4.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.2 | 8.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.2 | 3.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 9.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.2 | 1.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.2 | 8.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 1.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.2 | 20.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.2 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 2.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 4.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.2 | 3.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 1.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 3.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 3.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 1.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 4.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 2.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.2 | 4.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.2 | 2.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.2 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.1 | 3.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 5.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 2.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 2.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 6.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 0.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 0.9 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.1 | 1.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.1 | 5.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 0.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 2.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 2.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 1.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 5.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.1 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 4.8 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 4.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 1.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 3.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 3.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 2.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 3.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 1.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 2.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 2.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 2.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 2.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 3.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 0.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 1.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 2.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 1.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 5.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.1 | 3.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 4.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 3.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 1.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 2.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 1.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 2.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 1.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 2.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.1 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 4.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 3.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 2.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.1 | 1.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 3.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 3.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 4.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 2.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 1.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 5.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 1.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 5.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 4.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 9.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 5.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 3.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 2.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 1.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 1.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 0.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 3.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 4.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 3.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 6.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 1.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 1.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 5.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.1 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 1.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 8.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 1.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.1 | 1.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 0.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 1.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 0.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 0.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.1 | 4.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 14.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 1.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 3.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.0 | 6.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.6 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.0 | 0.7 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.0 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 8.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.0 | 3.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 2.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.0 | 0.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.0 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.8 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
| 0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 1.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 1.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 1.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.0 | 0.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 0.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 1.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 2.2 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.0 | 0.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 1.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 1.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 0.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
| 0.0 | 0.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |